How to Build the Internal Business Case for a Perfusion Cost Review

Often the person who first suspects that perfusion is overspending is not the person who approves the review — a service-line director, a quality leader, or a finance analyst who has to convince someone above them. This piece is for that person: how to make the internal case.

Lead with the asymmetry

The most persuasive feature of a perfusion cost review is its risk-return profile. The ask is small — a bounded assessment. The potential return is large — perfusion is frequently a six-figure opportunity in mid-sized and larger programs. And the downside is minimal, because a good review changes analysis and negotiation, not clinical practice. Frame it as one of the lowest-risk financial initiatives on the table.

Preempt the three objections you will hear

Bring one number to the meeting

You do not need a full analysis to justify starting one. A single defensible figure — your fully loaded perfusion supply cost per case, even roughly estimated — compared against a national range is usually enough to make the opportunity concrete. Specificity beats generality every time you are asking for a decision.

Make the ask small and specific

Do not ask for a transformation. Ask for a defined, time-boxed assessment with a clear deliverable: a prioritized savings roadmap with ROI projections. A narrow, concrete ask is far easier to approve than an open-ended engagement — and the roadmap it produces makes every subsequent decision easier to justify.